BioMarin Pharmaceutical Inc.

BU Lead Enzyme Therapies, Germany

BioMarin Pharmaceutical Inc.  •  Federal Republic of Germany (Hybrid)  •  2 hours ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

Who We Are

BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions.

Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered a portfolio of therapies since our founding in 1997. Our revolutionary treatments for conditions like achondroplasia (the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS (mucopolysaccharidosis) offer new possibilities for patients and families who previously had few, if any, available options. More recently, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease, expanding our ability to reach more people living with rare genetic conditions.

Our success comes from our unwavering commitment to excellence, our deep understanding of patient needs, our scientific expertise, and our world-class manufacturing capabilities. At the heart of BioMarin is a dedicated team of the brightest minds in the industry working together to deliver innovative therapies to patients and families around the world.

About Commercial

Be part of the worldwide infrastructure that gets our drugs to underserved patients around the world. Our global sales force solidifies BioMarin’s commercial presence in the United States and Europe and is rapidly growing in other regions, such as South America, EuMEA, and Asia-Pacific.

Business Unit Lead, Enzyme Therapies – Frankfurt, Germany
Hybrid role
Closing date 6 July 2026
Description

Reporting to the Country Manager Germany, the Business Unit Lead leads BioMarin’s Enzyme Therapies business in Germany. The role leads and develops a marketing and sales team to deliver revenue objectives and manage operating expenses for the Enzyme Therapies franchise spanning several products related to lysosomal and rare metabolic conditions.

The Business Unit Lead works across three organisations: leading the local German Enzyme Therapies team, partnering with the Global Enzyme Therapies Business Unit on brand strategy, lifecycle, and indication expansion, and aligning with the regional EUCAN Enzyme Therapies organisation on subregional brand plans, market access, and best-practice sharing. Success requires strategic agility, business acumen, people leadership, and the ability to work collaboratively across a matrix organisation.

Patient centricity is central to BioMarin’s mission. The ideal candidate will be equally inspired by the needs of the lysosomal/rare metabolic disease community and driven to expand patient access to therapy.

Key Responsibilities

  • Define and execute the commercial strategy for the Enzyme Therapies franchise in Germany, translating global and EUCAN brand strategy into a localised plan that delivers revenue and patient-access goals.
  • Lead, coach, and develop the German Enzyme Therapies team; build capability, set ambitious but achievable targets, and manage performance.
  • Own the German Enzyme Therapies budget; develop sales plans aligned to revenue goals and available resources, and manage spend with clear direction.
  • Partner with the Global Enzyme Therapies BU on brand planning, competitive positioning, and lifecycle priorities; bring the German market perspective into global forums.
  • Align with regional EUCAN Enzyme Therapies leadership on subregional brand plans, market access strategy, and cross-country knowledge sharing.
  • Drive cross-functional collaboration with Market Access, Medical Affairs, Marketing, Patient Advocacy, and Commercial Operations to ensure coordinated execution.
  • Spend time in the field with customers and KOLs, gathering insight and acting as the “voice of the customer” back into brand and regional teams.
  • Build and maintain strong relationships with key opinion leaders, treating centers, and the patient community.
  • Ensure all activities are conducted in full compliance with BioMarin policies, local regulations, and industry codes, role-modelling the highest standards of ethics and integrity.

Experience & Qualifications

  • Significant pharmaceutical/biotech commercial experience (5+ years), including field sales management and leadership of teams.
  • Proven track record in rare disease, specialty, or innovative medicines; experience in lysosomal diseases, paediatrics, endocrinology, or related therapeutic areas is a strong advantage.
  • Demonstrated people-leadership and management expertise; hiring, building, developing, and motivating commercial teams.
  • Strong business acumen and budget ownership; results-oriented with a sense of urgency and the judgment to adjust when goals are not met.
  • Ability to operate effectively in a matrix environment, influencing and gaining cooperation without direct authority.
  • Comfortable in an entrepreneurial, lean commercial environment, with an understanding of the constraints of a focused rare-disease organisation.
  • Excellent communication and presentation skills; able to build credibility with KOLs, payers, and internal stakeholders.
  • Deep commitment to compliance and to patient advocacy on behalf of the metabolic diseases community.
  • Fluent German and English (written and spoken).
  • Willingness to travel.


Note: This description is not intended to be all-inclusive, or a limitation of the duties of the position. It is intended to describe the general nature of the job that may include other duties as assumed or assigned.

Equal Opportunity Employer/Veterans/Disabled

An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.

BioMarin Pharmaceutical Inc.

About BioMarin Pharmaceutical Inc.

Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of the genetic conditions that it seeks to treat, helping to better the lives of those struggling with rare genetic disease. BioMarin discoveries have led to eight first or best-in-class commercial treatments and a pipeline of multiple product candidates applying the same science-driven, patient-forward approach to broader group of genetic disorders. The more innovative solutions developed, the more lives BioMarin can impact.

Recruitment Fraud Alert Notice

Please be aware of fraud or scams from individuals, organizations and/or internet sites claiming to represent BioMarin in recruitment activities. We have an established recruitment process which is required for all posted positions by BioMarin prior to issuing an offer of employment. This BioMarin process requires formal interviews conducted live with personnel representing BioMarin and never requires payments or fees from job applicants. BioMarin does not conduct interviews via texting tools such as RingCentral.

In the event you receive a suspicious email message about recruiting on behalf of BioMarin, unless it’s from a BioMarin authorized recruiting partner, do not provide any personal information or pay any fees. Qualified and interested candidates should apply to current openings directly through this BioMarin website. BioMarin accepts no responsibility for any costs or charges incurred as a result of fraudulent activity.

If you have lost money or provided your personal identifying information, please contact your bank and report the matter to the FBI via www.ic3.gov. We would also suggest you notify your local police department and monitor your credit.

We appreciate your interest in BioMarin & encourage you to visit http://careers.biomarin.com/career-areas to review job opportunities.

Industry
Biotech & Life Sciences
Company Size
1,001-5,000 employees
Headquarters
San Rafael, CA
Year Founded
1997
Social Media